Scenarios that move ARGX
argenx SE - American Depositary Shares
Scenarios that move ARGX: 3 analyses, 2 positive, 1 negative.
- · argenx meets primary endpoint in Phase II celiac disease study — ▲ · impact +90 · confidence high · horizon immediate
- · HALO wins court order blocking Merck's European Keytruda SC — ▲ · impact +25 · confidence low · horizon quarters
- · Novartis acquires Abogen in $7.8B RNA therapeutics deal — ▼ · impact -20 · confidence low · horizon quarters